Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Swisher

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|December 30, 2020
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutationsTalayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2021
Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube ModelsLaura J Mauro, Megan I Seibel, Caroline H Diep, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Characterization of splice-altering mutations in inherited predisposition to cancerSilvia Casadei, Suleyman Gulsuner, Brian H Shirts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative NeoplasmsKeith W Pratz, Brian D Koh, Anand G Patel, et al.
American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|December 30, 2020
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutationsTalayeh S Ghezelayagh, Kathryn P Pennington, Barbara M Norquist, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2021
Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube ModelsLaura J Mauro, Megan I Seibel, Caroline H Diep, et al.
Science Translational Medicine|July 20, 2022
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.
Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Characterization of splice-altering mutations in inherited predisposition to cancerSilvia Casadei, Suleyman Gulsuner, Brian H Shirts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative NeoplasmsKeith W Pratz, Brian D Koh, Anand G Patel, et al.
American Journal of Obstetrics and Gynecology|June 20, 2026
International Trends in Concurrent Hysterectomy at Risk-Reducing Surgery in BRCA1/2 pathogenic variant carriers: A mixed-methods studyTamar A Gootzen, Barbara M Norquist, Roni Nitecki Wilke, et al.
Pageof 20